New hope for prostate cancer patients: can erectile function be restored?
NCT ID NCT07302451
First seen Jan 08, 2026 · Last updated May 14, 2026 · Updated 22 times
Summary
This study looks at whether men with prostate cancer can regain erectile function and improve quality of life after stopping hormone therapy and receiving radiotherapy. About 50 men will take a hormone drug (Relugolix) followed by radiation, then fill out questionnaires on sexual health and well-being. The main goal is to see if at least 70% of participants recover erectile function within six months after finishing hormone therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale - Napoli
Naples, 80131, Italy
Conditions
Explore the condition pages connected to this study.